Ernestas Sirka

Ernestas Sirka is the Chief Scientific Officer & Co-Founder at Inoviv, where Ernestas accelerates the development of new medicines with targeted proteomics and mass spectrometry-based biomarkers. Prior to this, Ernestas was a member of the EF9 cohort at Entrepreneur First, the world’s leading talent investor. Ernestas also worked at University College London, focusing on translational biomarker research and developing assays for neurological disorders. Ernestas gained experience in pharmaceutical sciences at Pfizer and holds a MBiol (First-class Hons) in Molecular & Cellular Biology from the University of Bath. Ernestas also achieved the highest academic achievements at Vilnius Lyceum.